Erratum: Preoperative Chemosensitivity Testing as Predictor of Treatment Benefit in Adjuvant Stage III Colon Cancer (PePiTA): Protocol of a Prospective BGDO (Belgian Group for Digestive Oncology) Multicentric Study

BMC Cancer - United Kingdom
doi 10.1186/s12885-015-1181-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CTCs as a Prognostic and Predictive Biomarker for Stage II/III Colon Cancer: A Companion Study to the PePiTA Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Safety of UFT/LV and S-1 as Adjuvant Therapy for Stage III Colon Cancer in Phase III Trial: ACTS-CC Trial

British Journal of Cancer
Cancer ResearchOncology
2012English

Factors Associated With Delayed Time to Adjuvant Chemotherapy in Stage Iii Colon Cancer

Current Oncology
Oncology
2014English

Preoperative Prognostic Nutritional Index Is a Powerful Predictor of Prognosis in Patients With Stage III Ovarian Cancer

Scientific Reports
Multidisciplinary
2017English

P-0218 * Timing and Regimens of Adjuvant Therapy for Resected Stage Ii and Iii Colon Cancer

Annals of Oncology
MedicineOncologyHematology
2014English

Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70

PLoS ONE
Multidisciplinary
2015English

Adjuvant Therapy After Preoperative Treatment for Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2009English

Adjuvant Therapy in Stage II Colon Cancer: Current Approaches

Oncologist
Cancer ResearchMedicineOncology
2005English

Comparison of Adverse Events During 5-Fluorouracil Versus 5-Fluorouracil/Oxaliplatin Adjuvant Chemotherapy for Stage III Colon Cancer

Cancer
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy